Inhibrx Biosciences, Inc. (INBX) KPIs and segments
INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$77.66−5.64 (-6.77%)
Close on Nov 16, 2026Market cap $1.14BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Inhibrx Biosciences's business
Coming soon
This tab will track the numbers specific to Inhibrx Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?